Dr. Michael Gallaway is an associate professor of optometry at the Pennsylvania College of Optometry (PCO) at Salus University in Philadelphia. He is also in private practice in Marlton, NJ specializing in pediatric optometry and vision therapy. His research interests include the efficacy of vision therapy, the impact of concussions on visual function, amblyopia, the impact of vision disorders on reading and learning, and school vision screening protocols. He is currently the Principal Investigator at PCO for the nationwide study, Convergence Insufficiency Treatment Trial: Attention and Reading Trial (CITT-ART.co m). He was the Pl at PCO for the CITT study published in 2008, and has been a clinical investigator for PEDIG for the Amblyopia Treatment Studies. He is a Fellow of The College of Optometrists in Vision Development (COVD) and the American Academy of Optometry. He received the Skeffington Award for excellence in optometric writing from COVD in 2015.